Literature DB >> 11705906

CD8(+)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice.

W L Chang1, S P Jones, D J Lefer, T Welbourne, G Sun, L Yin, H Suzuki, J Huang, D N Granger, H C van der Heyde.   

Abstract

The Plasmodium berghei-infected mouse model is a well-recognized model for human cerebral malaria. Mice infected with P. berghei exhibit (i) metabolic acidosis (pH < 7.3) associated with elevated plasma lactate concentrations, (ii) significant (P < 0.05) vascular leakage in their lungs, hearts, kidneys, and brains, (ii) significantly (P < 0.05) higher cell and serum glutamate concentrations, and (iv) significantly (P < 0.05) lower mean arterial blood pressures. Because these complications are similar to those of septic shock, the simplest interpretation of these findings is that the mice develop shock brought on by the P. berghei infection. To determine whether the immune system and specifically CD8(+) T cells mediate the key features of shock during P. berghei malaria, we depleted CD8(+) T cells by monoclonal antibody (mAb) treatment and assessed the complications of malarial shock. P. berghei-infected mice depleted of CD8(+) T cells by mAb treatment had significantly reduced vascular leakage in their hearts, brains, lungs, and kidneys compared with infected controls treated with rat immunoglobulin G. CD8-depleted mice were significantly (P < 0.05) protected from lactic acidosis, glutamate buildup, and diminished HCO(3)(-) levels. Although the blood pressure decreased in anti-CD8 mAb-treated mice infected with P. berghei, the cardiac output, as assessed by echocardiography, was similar to that of uninfected control mice. Collectively, our results indicate that (i) pathogenesis similar to septic shock occurs during experimental P. berghei malaria, (ii) respiratory distress with lactic acidosis occurs during P. berghei malaria, and (iii) most components of circulatory shock are ameliorated by depletion of CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705906      PMCID: PMC98820          DOI: 10.1128/IAI.69.12.7341-7348.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique.

Authors:  H C van der Heyde; P Bauer; G Sun; W L Chang; L Yin; J Fuseler; D N Granger
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 2.  T-cell function and migration. Two sides of the same coin.

Authors:  U H von Andrian; C R Mackay
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

Review 3.  Cytokines in malaria, pathology and protection.

Authors:  W M Eling; P G Kremsner
Journal:  Biotherapy       Date:  1994

4.  Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice.

Authors:  M R Hoffmeyer; S P Jones; C R Ross; B Sharp; M B Grisham; F S Laroux; T J Stalker; R Scalia; D J Lefer
Journal:  Circ Res       Date:  2000-10-27       Impact factor: 17.367

5.  Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam.

Authors:  H C Brown; T T Chau; N T Mai; N P Day; D X Sinh; N J White; T T Hien; J Farrar; G D Turner
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

6.  Cerebral malaria in inbred mice. I. A new model and its pathology.

Authors:  J R Rest
Journal:  Trans R Soc Trop Med Hyg       Date:  1982       Impact factor: 2.184

7.  Do patients with cerebral malaria have cerebral oedema? A computed tomography study.

Authors:  S Looareesuwan; D A Warrell; N J White; P Sutharasamai; P Chanthavanich; K Sundaravej; B E Juel-Jensen; D Bunnag; T Harinasuta
Journal:  Lancet       Date:  1983-02-26       Impact factor: 79.321

8.  Virulent P. berghei malaria: prolonged survival and decreased cerebral pathology in cell-dependent nude mice.

Authors:  R W Finley; L J Mackey; P H Lambert
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

9.  Immunopathological aspects of Plasmodium berghei infection in five strains of mice. II. Immunopathology of cerebral and other tissue lesions during the infection.

Authors:  L J Mackey; A Hochmann; C H June; C E Contreras; P H Lambert
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

10.  T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views.

Authors:  J A Ledbetter; R V Rouse; H S Micklem; L A Herzenberg
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more
  27 in total

1.  Genome-wide expression profiling in malaria infection reveals transcriptional changes associated with lethal and nonlethal outcomes.

Authors:  Kurt Schaecher; Sanjai Kumar; Anjali Yadava; Maryanne Vahey; Christian F Ockenhouse
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Protein kinase C-theta is required for development of experimental cerebral malaria.

Authors:  Mathilde Fauconnier; Marie-Laure Bourigault; Sandra Meme; Frederic Szeremeta; Jennifer Palomo; Adeline Danneels; Sabine Charron; Lizette Fick; Muazzam Jacobs; Jean-Claude Beloeil; Bernhard Ryffel; Valerie F J Quesniaux
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

3.  Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria.

Authors:  Adriana A Marin; Oscar Murillo; Rodrigo A Sussmann; Luana S Ortolan; Daniella S Battagello; Thatyane de Castro Quirino; Jackson C Bittencourt; Sabrina Epiphanio; Alejandro M Katzin; Leonardo J M Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2021-03-01       Impact factor: 5.191

4.  Platelets activate a pathogenic response to blood-stage Plasmodium infection but not a protective immune response.

Authors:  Irene Gramaglia; Joyce Velez; Valery Combes; Georges E R Grau; Melanie Wree; Henri C van der Heyde
Journal:  Blood       Date:  2017-01-17       Impact factor: 22.113

5.  The natural killer complex regulates severe malarial pathogenesis and influences acquired immune responses to Plasmodium berghei ANKA.

Authors:  Diana S Hansen; Krystal J Evans; Marthe C D'Ombrain; Nicholas J Bernard; Adrienne C Sexton; Lynn Buckingham; Anthony A Scalzo; Louis Schofield
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Kynurenine is an endothelium-derived relaxing factor produced during inflammation.

Authors:  Yutang Wang; Hanzhong Liu; Gavin McKenzie; Paul K Witting; Johannes-Peter Stasch; Michael Hahn; Dechaboon Changsirivathanathamrong; Ben J Wu; Helen J Ball; Shane R Thomas; Vimal Kapoor; David S Celermajer; Andrew L Mellor; John F Keaney; Nicholas H Hunt; Roland Stocker
Journal:  Nat Med       Date:  2010-02-28       Impact factor: 53.440

7.  Effects of anti-inflammatory vagus nerve stimulation in endotoxemic rats on blood and spleen lymphocyte subsets.

Authors:  S Mihaylova; H Schweighöfer; H Hackstein; B Rosengarten
Journal:  Inflamm Res       Date:  2014-05-07       Impact factor: 4.575

8.  Comparative study of brain CD8+ T cells induced by sporozoites and those induced by blood-stage Plasmodium berghei ANKA involved in the development of cerebral malaria.

Authors:  Sébastien Bagot; Fatima Nogueira; Alexis Collette; Virgilio do Rosario; François Lemonier; Pierre-André Cazenave; Sylviane Pied
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  S-Nitrosoglutathione Reductase Deficiency Confers Improved Survival and Neurological Outcome in Experimental Cerebral Malaria.

Authors:  Robyn E Elphinstone; Rickvinder Besla; Eric A Shikatani; Ziyue Lu; Alfred Hausladen; Matthew Davies; Clinton S Robbins; Mansoor Husain; Jonathan S Stamler; Kevin C Kain
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

10.  Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients.

Authors:  Jorge Monserrat; Raul de Pablo; Eduardo Reyes; David Díaz; Hugo Barcenilla; Manuel R Zapata; Antonio De la Hera; Alfredo Prieto; Melchor Alvarez-Mon
Journal:  Crit Care       Date:  2009-02-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.